Preventing a return of breast cancer in young women is more effective with a new treatment option than using tamoxifen, reveals the results of two international trials released Sunday. The findings show that exemestane, given along with treatment to suppress the function of the ovaries, reduced the risk of breast cancer's return by 34 percent, and cut the risk of a subsequent invasive cancer by 28 percent. Exemestane is an aromatase inhibitor that until ...
via Medindia Health News More READ
No comments:
Post a Comment